Keyphrases
Schizophrenia
100%
Novel Therapeutics
100%
Functional Outcome
100%
Early Intervention
100%
Selective Review
100%
Schizophrenic Patients
80%
At-risk Mental State
60%
Morphological Changes
60%
Cognitive Impairment
40%
Psychosis
40%
Negative Symptoms
40%
Thalamic
40%
Chronic Stage
40%
Fronto
40%
Event-related Potentials
20%
N-methyl-D-aspartate Receptor (NMDAR)
20%
Recovery Rate
20%
Dendritic Spines
20%
Superior Temporal Gyrus
20%
Positive Psychotic Symptoms
20%
Behavior Change
20%
Frontal Cortex
20%
Volume Reduction
20%
Lateral Ventricle
20%
Behavioral Abnormalities
20%
Mismatch Negativity
20%
Histological Abnormalities
20%
Intervention Studies
20%
Animal Model of Schizophrenia
20%
Cognitive Performance
20%
Pyramidal Neurons
20%
Structural Neuroimaging
20%
Insula
20%
Neuroimaging Studies
20%
Histological Changes
20%
Perisylvian Region
20%
Brain Morphology
20%
Pathophysiological Basis
20%
Parvalbumin Interneurons
20%
Duration of Untreated Psychosis
20%
Hypofunction
20%
Perisylvian
20%
Symptom Change
20%
Transition Risk
20%
Syndrome Classification
20%
Neurocognitive Dysfunction
20%
Long-term Recovery
20%
Antioxidant Compounds
20%
Performance Event
20%
Neuroscience
Cognitive Disorders
100%
Negative Syndrome
100%
Event-Related Potential
50%
Parvalbumin
50%
Dendritic Spine
50%
Superior Temporal Gyrus
50%
Frontal Lobe
50%
Lateral Ventricle
50%
Mismatch Negativity
50%
Antioxidant
50%
Interneuron
50%
Dextro Aspartic Acid
50%
Receptor
50%